Search details
1.
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" study.
Cancer Immunol Immunother
; 70(6): 1583-1592, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33231726
2.
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients.
Front Oncol
; 13: 1125013, 2023.
Article
in English
| MEDLINE | ID: mdl-36895480
3.
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Curr Oncol
; 30(6): 5456-5469, 2023 06 04.
Article
in English
| MEDLINE | ID: mdl-37366896
4.
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.
Cancers (Basel)
; 15(24)2023 Dec 08.
Article
in English
| MEDLINE | ID: mdl-38136304
5.
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study).
Cancers (Basel)
; 13(9)2021 Apr 27.
Article
in English
| MEDLINE | ID: mdl-33925278
6.
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
Clin Lung Cancer
; 22(4): 351-360, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33558194
7.
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
Clin Colorectal Cancer
; 20(4): 318-325, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34380594
8.
Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives.
Cancers (Basel)
; 12(5)2020 May 08.
Article
in English
| MEDLINE | ID: mdl-32397295
9.
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report.
Clin Colorectal Cancer
; 20(4): 364-367, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34629317
Results
1 -
9
de 9
1
Next >
>>